The aim of this study is to identify the effect of remote ischemic preconditioning on troponin I.The individuals will be randomized using sealed envelopem and the study will be double blind and unicentral clinical trial. IFor the purpose of this study 28 patients will be chosen and will be divided to two equal groups(14 case and 14 control). Including criteria: ASA 2 or 3, normal troponin I level, no recent myocardial infarction, ejection fraction more than 35%, no renal and hepatic dysfunction, no arterio-venous fistula, no lymph edema.
Excluding criteria: ASA 4 or more, elevated baseline troponin I, myocardial infarction in recent 4 weeks, ejection fraction less than 35%, renal dysfunction, arterio venous fistula, lymph edema, severe endocrine or hepatic dysfunction.
At first, two mililiter of patient's arterial blood will be send to laboratory for measurement of baseline troponin I. In case group after induction of anesthesia and intubation, pneumatic torniquet will inflate for 5 minutes up to 200 mmHg on the upper arm and deflate for 5 minutes.This cycle will be repeated two times.Second and third samples will be send to labaratory at 6,24 hour after the first sample.After remote ischemic preconditioning troponin I level, intubation time,inotrop requirement and patient hemodynamic during and after surgery will be evaluated.In control group after induction of anesthesia and intubation pneumatic torniquet will be set on the right upper limb but will not be inflated and blood samples will be send to laboratory like case group.